Contact information
hooman.soleymanimajd@msd.ox.ac.uk
Ms Zoe Risk
office@gynaecologycareoxford.co.uk
http://www.gynaecologycareoxford.co.uk
https://orcid.org/0000-0003-3293-5321
He/Him
Biography
Mr. Hooman Soleymani majd is a highly skilled consultant in gynaecological oncology at the Churchill cancer centre in Oxford, a position he has held since 2017. He began his obstetrics and gynaecology career in London and completed his structured postgraduate training in Oxford, obtaining a certificate of completion of training and membership in the Royal College of Obstetricians and Gynaecologists. He further honed his expertise with three years of sub-specialty training in gynaecological oncology at the Churchill cancer centre.
A BSCCP-accredited colposcopist and trainer, Mr. Soleymani Majd is a member of the British Gynaecological Cancer Society (BGCS), International Society for Placenta Accreta Spectrum (IS-PAS) and the European Society of Gynaecological Oncology (ESGO). He is an accomplished surgeon, with particular expertise in ultra-radical surgery for advanced ovarian cancer, including upper abdominal surgery, liver mobilisation, and diaphragmatic reconstruction. He also has a dedicated interest in the surgical management of Placenta Accreta Spectrum (PAS) and is a founding member of the OxPAT group. Additionally, Mr. Soleymani majd is a member of the Oxford complex pelvic surgery (exenterative surgery) and sarcoma team. Beyond his clinical expertise, Mr. Soleymani majd is deeply committed to medical education, mentoring registrars, fellows and students at Oxford University. He is involved in research on advanced surgical techniques for ovarian cancer, with multiple publications on the subject in leading journals. He has also recently commissioned a special series of high impact articles on “Evolutions in the management of advanced ovarian cancer” for the Gynaecology and Pelvic Medicine journal.
He has a number of past and on-going collaborations with acclaimed researchers in the United Kingdom and abroad. He has authored book chapters and published prolifically in high impact peer-reviewed journal through the years. He is the co-editor for a new Oxford Surgical Handbook, which is currently being written and due to be published by Oxford University Press in due course. An invited speaker at numerous international congresses and webinars, he serves on the editorial boards of four international journals and has recently been appointed associate Editor-in-Chief of Translational Cancer Research (TCR).
Mr. Soleymani majd serves as a visiting Professor at Guangxi Medical University Cancer Hospital in Nanning, China. In addition to his NHS work, he sees private patients at Nuffield Health, the Manor Hospital and between 2021 and 2024, he was awarded the iWantGreatCare certificate of excellence for outstanding patient care. Mr. Soleymani majd is passionate about teaching, research and committed to delivering the highest standards of patient care.
Hooman Soleymani majd
MD, MRCOG
Honorary Senior Clinical Lecturer
- Consultant Obstetrician & Gynaecologist
- Sub-specialist in Gynaecological Oncology Surgery
Oxford Collaborators
International Collaborators
Green Surgery Collaborative
COVIDSurg Collaborative
STARSurg Collaborative
Professor Federico Ferrari : University of Brescia, Italy
Professor Sarosh Irani : Mayo Clinic, Florida, USA
Key publications
-
GreenSurg Collaborative None., (2023), Br J Surg, 110, 508 - 510
-
Hu Z. et al, (2020), Cancer Cell, 37, 226 - 242.e7
-
Soleymani Majd H. et al, (2024), Eur J Obstet Gynecol Reprod Biol, 299, 148 - 155
-
Soleymani Majd H. et al, (2021), Am J Obstet Gynecol, 225, 175.e1 - 175.e10
Recent publications
-
Nistor SI. and Soleymani Majd H., (2024), Transl Cancer Res, 13, 5664 - 5677
-
Ferrari F. et al, (2024), International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
-
El Tawab S. et al, (2024), Translational Cancer Research, 13, 5037 - 5049
-
Aggarwal A. et al, (2024), Diseases, 12
-
Henning TJ. et al, (2024), Clin Case Rep, 12
-
Ferrari F. et al, (2024), Cancers (Basel), 16
-
Forder BH. et al, (2024), Clin Case Rep, 12
-
Ramachandran R. et al, (2024), Clin Case Rep, 12
-
Bruguier H. et al, (2024), Clinical Case Reports, 12
-
Soleymani Majd H. et al, (2024), Eur J Obstet Gynecol Reprod Biol, 299, 148 - 155
-
Nistor SI. et al, (2024), Int J Gynecol Cancer
-
Darwish A. et al, (2024), Eur J Surg Oncol, 50
-
Ferrari F. et al, (2024), Gynecol Obstet Invest
-
Ferrari F. et al, (2024), Oncol Rev, 18
-
Shao R. et al, (2024), Front Surg, 11